|
ASX - By Stock
|
FDV |
Re:
Ann: Change of Director' Interest Notice - L. Elliott
|
|
Friendsandco
|
2 |
470 |
0 |
20/04/26 |
| 20/04/26 |
ASX - By Stock
|
2
|
470
|
0
|
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm Achieves 50% Patient Dosing in Phase 3
|
|
Friendsandco
|
166 |
43K |
1 |
15/04/26 |
| 15/04/26 |
ASX - By Stock
|
166
|
43K
|
1
|
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm Achieves 50% Patient Dosing in Phase 3
|
|
Friendsandco
|
166 |
43K |
5 |
15/04/26 |
| 15/04/26 |
ASX - By Stock
|
166
|
43K
|
5
|
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm Achieves 50% Patient Dosing in Phase 3
|
|
Friendsandco
|
166 |
43K |
0 |
15/04/26 |
| 15/04/26 |
ASX - By Stock
|
166
|
43K
|
0
|
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm Achieves 50% Patient Dosing in Phase 3
|
|
Friendsandco
|
166 |
43K |
0 |
15/04/26 |
| 15/04/26 |
ASX - By Stock
|
166
|
43K
|
0
|
|
|
ASX - By Stock
|
PAR |
Re:
PAR - Broker Data
|
|
Friendsandco
|
154 |
49K |
0 |
14/04/26 |
| 14/04/26 |
ASX - By Stock
|
154
|
49K
|
0
|
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm Achieves 50% Patient Dosing in Phase 3
|
|
Friendsandco
|
166 |
43K |
1 |
14/04/26 |
| 14/04/26 |
ASX - By Stock
|
166
|
43K
|
1
|
|
|
ASX - By Stock
|
PAR |
Re:
General OA media and info
|
|
Friendsandco
|
796 |
332K |
0 |
09/04/26 |
| 09/04/26 |
ASX - By Stock
|
796
|
332K
|
0
|
|
|
ASX - By Stock
|
PAR |
Re:
General OA media and info
|
|
Friendsandco
|
796 |
332K |
0 |
09/04/26 |
| 09/04/26 |
ASX - By Stock
|
796
|
332K
|
0
|
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Application for quotation of securities - PAR
|
|
Friendsandco
|
15 |
5.0K |
0 |
09/04/26 |
| 09/04/26 |
ASX - By Stock
|
15
|
5.0K
|
0
|
|
|
ASX - By Stock
|
PAR |
Re:
General OA media and info
|
|
Friendsandco
|
796 |
332K |
0 |
09/04/26 |
| 09/04/26 |
ASX - By Stock
|
796
|
332K
|
0
|
|
|
ASX - By Stock
|
PAR |
Re:
General OA media and info
|
|
Friendsandco
|
796 |
332K |
0 |
08/04/26 |
| 08/04/26 |
ASX - By Stock
|
796
|
332K
|
0
|
|
|
ASX - By Stock
|
PAR |
Re:
General OA media and info
|
|
Friendsandco
|
796 |
332K |
0 |
08/04/26 |
| 08/04/26 |
ASX - By Stock
|
796
|
332K
|
0
|
|
|
ASX - By Stock
|
FDV |
Re:
Ann: Executive Equity Incentive Scheme Update
|
|
Friendsandco
|
4 |
1.3K |
0 |
08/04/26 |
| 08/04/26 |
ASX - By Stock
|
4
|
1.3K
|
0
|
|
|
ASX - By Stock
|
PAR |
Re:
General OA media and info
|
|
Friendsandco
|
796 |
332K |
0 |
08/04/26 |
| 08/04/26 |
ASX - By Stock
|
796
|
332K
|
0
|
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm Announces OA Research Collaboration in UK
|
|
Friendsandco
|
10 |
3.5K |
1 |
08/04/26 |
| 08/04/26 |
ASX - By Stock
|
10
|
3.5K
|
1
|
|
|
ASX - By Stock
|
PAR |
Re:
Drug Effect Size and a bonus...
|
|
Friendsandco
|
12 |
4.2K |
2 |
06/04/26 |
| 06/04/26 |
ASX - By Stock
|
12
|
4.2K
|
2
|
|
|
ASX - By Stock
|
FDV |
Re:
Ann: Executive Equity Incentive Scheme Update
|
|
Friendsandco
|
4 |
1.3K |
0 |
02/04/26 |
| 02/04/26 |
ASX - By Stock
|
4
|
1.3K
|
0
|
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm Announces OA Research Collaboration in UK
|
|
Friendsandco
|
10 |
3.5K |
2 |
02/04/26 |
| 02/04/26 |
ASX - By Stock
|
10
|
3.5K
|
2
|
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm Achieves 50% Patient Dosing in Phase 3
|
|
Friendsandco
|
166 |
43K |
0 |
02/04/26 |
| 02/04/26 |
ASX - By Stock
|
166
|
43K
|
0
|
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm Achieves 50% Patient Dosing in Phase 3
|
|
Friendsandco
|
166 |
43K |
12 |
01/04/26 |
| 01/04/26 |
ASX - By Stock
|
166
|
43K
|
12
|
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm Achieves 50% Patient Dosing in Phase 3
|
|
Friendsandco
|
166 |
43K |
3 |
31/03/26 |
| 31/03/26 |
ASX - By Stock
|
166
|
43K
|
3
|
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Hong Kong Site Activated for Phase 3 OA Study
|
|
Friendsandco
|
64 |
18K |
5 |
31/03/26 |
| 31/03/26 |
ASX - By Stock
|
64
|
18K
|
5
|
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Hong Kong Site Activated for Phase 3 OA Study
|
|
Friendsandco
|
64 |
18K |
6 |
31/03/26 |
| 31/03/26 |
ASX - By Stock
|
64
|
18K
|
6
|
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm Achieves 50% Patient Dosing in Phase 3
|
|
Friendsandco
|
166 |
43K |
23 |
31/03/26 |
| 31/03/26 |
ASX - By Stock
|
166
|
43K
|
23
|
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Hong Kong Site Activated for Phase 3 OA Study
|
|
Friendsandco
|
64 |
18K |
4 |
31/03/26 |
| 31/03/26 |
ASX - By Stock
|
64
|
18K
|
4
|
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Hong Kong Site Activated for Phase 3 OA Study
|
|
Friendsandco
|
64 |
18K |
13 |
31/03/26 |
| 31/03/26 |
ASX - By Stock
|
64
|
18K
|
13
|
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Hong Kong Site Activated for Phase 3 OA Study
|
|
Friendsandco
|
64 |
18K |
7 |
31/03/26 |
| 31/03/26 |
ASX - By Stock
|
64
|
18K
|
7
|
|
|
ASX - By Stock
|
PAR |
Re:
Paradigm chief Paul Rennie on IPPS blockbuster potential, 50% phase three milestone
|
|
Friendsandco
|
101 |
31K |
4 |
20/03/26 |
| 20/03/26 |
ASX - By Stock
|
101
|
31K
|
4
|
|
|
ASX - By Stock
|
PAR |
Re:
Paradigm chief Paul Rennie on IPPS blockbuster potential, 50% phase three milestone
|
|
Friendsandco
|
101 |
31K |
1 |
16/03/26 |
| 16/03/26 |
ASX - By Stock
|
101
|
31K
|
1
|
|
|
ASX - By Stock
|
PAR |
Re:
Paradigm chief Paul Rennie on IPPS blockbuster potential, 50% phase three milestone
|
|
Friendsandco
|
101 |
31K |
5 |
14/03/26 |
| 14/03/26 |
ASX - By Stock
|
101
|
31K
|
5
|
|
|
ASX - By Stock
|
PAR |
Re:
Paradigm chief Paul Rennie on IPPS blockbuster potential, 50% phase three milestone
|
|
Friendsandco
|
101 |
31K |
9 |
12/03/26 |
| 12/03/26 |
ASX - By Stock
|
101
|
31K
|
9
|
|
|
ASX - By Stock
|
PAR |
Re:
Paradigm chief Paul Rennie on IPPS blockbuster potential, 50% phase three milestone
|
|
Friendsandco
|
101 |
31K |
8 |
09/03/26 |
| 09/03/26 |
ASX - By Stock
|
101
|
31K
|
8
|
|
|
ASX - By Stock
|
PAR |
Re:
Sell or partner what's your prediction/preferences
|
|
Friendsandco
|
66 |
15K |
2 |
03/03/26 |
| 03/03/26 |
ASX - By Stock
|
66
|
15K
|
2
|
|
|
ASX - By Stock
|
FDV |
Re:
Ann: Strategic Reset Delivers Structural Margin Expansion
|
|
Friendsandco
|
2 |
931 |
2 |
28/02/26 |
| 28/02/26 |
ASX - By Stock
|
2
|
931
|
2
|
|
|
ASX - By Stock
|
PAR |
Re:
The Dexa Scan and the Authority Shift...
|
|
Friendsandco
|
6 |
2.2K |
5 |
15/02/26 |
| 15/02/26 |
ASX - By Stock
|
6
|
2.2K
|
5
|
|
|
ASX - By Stock
|
PAR |
Re:
Chart P3 PAR
|
|
Friendsandco
|
30 |
9.6K |
16 |
14/02/26 |
| 14/02/26 |
ASX - By Stock
|
30
|
9.6K
|
16
|
|
|
ASX - By Stock
|
PAR |
Re:
Chart P3 PAR
|
|
Friendsandco
|
30 |
9.6K |
6 |
13/02/26 |
| 13/02/26 |
ASX - By Stock
|
30
|
9.6K
|
6
|
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Published Canine Study Strengthens iPPS Phase 3 Rationale
|
|
Friendsandco
|
41 |
11K |
11 |
11/02/26 |
| 11/02/26 |
ASX - By Stock
|
41
|
11K
|
11
|
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Published Canine Study Strengthens iPPS Phase 3 Rationale
|
|
Friendsandco
|
41 |
11K |
10 |
11/02/26 |
| 11/02/26 |
ASX - By Stock
|
41
|
11K
|
10
|
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Oral OA Animal Therapy Progresses via AVet Deal
|
|
Friendsandco
|
26 |
8.4K |
4 |
09/02/26 |
| 09/02/26 |
ASX - By Stock
|
26
|
8.4K
|
4
|
|
|
ASX - By Stock
|
PAR |
Re:
Ann: iPPS Phase 2 Biomarker Results Published in Leading Journal
|
|
Friendsandco
|
31 |
11K |
9 |
28/01/26 |
| 28/01/26 |
ASX - By Stock
|
31
|
11K
|
9
|
|
|
ASX - By Stock
|
PAR |
Re:
Section 507, DDT and the not so Binary Play?
|
|
Friendsandco
|
25 |
6.4K |
8 |
18/01/26 |
| 18/01/26 |
ASX - By Stock
|
25
|
6.4K
|
8
|
|
|
ASX - By Stock
|
FDV |
Re:
Ann: Business Review, FY25 Guidance, Latam ESOP Disclosure
|
|
Friendsandco
|
18 |
6.1K |
1 |
30/12/25 |
| 30/12/25 |
ASX - By Stock
|
18
|
6.1K
|
1
|
|
|
ASX - By Stock
|
FDV |
Re:
Ann: Business Review, FY25 Guidance, Latam ESOP Disclosure
|
|
Friendsandco
|
18 |
6.1K |
0 |
30/12/25 |
| 30/12/25 |
ASX - By Stock
|
18
|
6.1K
|
0
|
|
|
ASX - By Stock
|
FDV |
Re:
Ann: Business Review, FY25 Guidance, Latam ESOP Disclosure
|
|
Friendsandco
|
18 |
6.1K |
1 |
14/12/25 |
| 14/12/25 |
ASX - By Stock
|
18
|
6.1K
|
1
|
|
|
ASX - By Stock
|
FDV |
Re:
Ann: Executive Leadership Appointments
|
|
Friendsandco
|
1 |
1.0K |
0 |
05/11/25 |
| 05/11/25 |
ASX - By Stock
|
1
|
1.0K
|
0
|
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Letter to Shareholders, Notice of AGM & Proxy Form
|
|
Friendsandco
|
31 |
7.2K |
5 |
17/10/25 |
| 17/10/25 |
ASX - By Stock
|
31
|
7.2K
|
5
|
|
|
ASX - By Stock
|
OCC |
Re:
OCC Trading
|
|
Friendsandco
|
2.8K |
1.0M |
5 |
02/10/25 |
| 02/10/25 |
ASX - By Stock
|
2.8K
|
1.0M
|
5
|
|
|
ASX - By Stock
|
OCC |
Re:
Ann: First Distributor signed for Remplir in $75m Canadian Market
|
|
Friendsandco
|
35 |
8.8K |
5 |
30/09/25 |
| 30/09/25 |
ASX - By Stock
|
35
|
8.8K
|
5
|
|